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IIOCHEMISTS have been struggling for the last fifty years to finld some specific
markers to distinguish a malignant tumour from normal cells. Attempts are
also being made to characterise the rate of growth of tumours by their enzyme
properties. Histologically tumours have distinctive characteristics on the basis
of which they are classified and identified with accuracy. These differences
should be attributed to an altered intermediary metabolism or other level of
cellular activity. It thus seems logical to search for some specific parameters
of these various types of tumours.
The present authors are engaged in search of specific markers of histologically
well defined tumours. In our early work (Divekar and Bhide, 1962) two tumour
types, namely mammary adenocarcinoma in C3H (Jax) strain and fibrosarcoma
in Swiss strain were used. Preliminary observations on nucleic acids shoTed
significant differences in nucleic acid levels and RNA/DNA ratio ofthese tumours.
However, these two tumours were maintained in serial transplantation and had
undergone progression, hence it was not possible to attribute these observed
differences to the tumour type alone or to the degree of progression of these
tumours or to their different growth rates. To ascertain this point a variety of
mammary adenocarcinomas in virgins and breeders ofdifferent susceptible strains,
carcinomas of different tissue origins, as well as induced primdry fibrosarcomas
in tWo strains were clhosen for comparison. Nucleic acid levels, ribonuclease,
acid and alkaline phosphatases and adenosine triphosphatase activities of these
tumours were measured. The present paper deals with these observations.
MATERIAL AND METHODS
Thefollowing tumour types in C3H (Jax), ICRC, Strong A and Swiss strain mice
were used for experimental purposes. The ICRC strain, which is newly developed
in our laboratory, is highly susceptible to breast cancer (Ranadive et al., 1961).
l. Spontaneous mammary adenocarcinomas
(a) in C3H (Jax) virgins,
(b) in C3H (Jax) breeders,
(c) in ICRC virgins,
(d) in ICRC breeders,
(e) in Strong A breeders.
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2. Induced primary fibrosarcomas
(i) Methylcholanthrene (MCA) induced in Swiss strain,
(ii) In C3H (Jax) strain (fibroblasts of C3H mouse were treated with MCA
in vitro. These treated cells were then injected subcutaneously in
C3H males.
:3. First generation of transplanted carcinomas of different tissue origins
(a) Liver tumours in ICRC strain,
(b) Liver tumours in Strong A straini,
(c) Cervical tumour in Strong A strain,
(d) Lung tumour in Swiss strain.
4. Ascites tumour
Animals were killed when the tumour was 2 X 2 cm. in size. The observations
represent mean value of six tumour samples. Tumour was homogenised in a
Potter Elvehjem homogeniser in cold distilled water to make it about 10%.
The homogenate was used for different estimations.
1. Estimation of ribonucleic acid (RNA) was carried out by Ogur and Rosen's
method (1950).
2. Deoxyribonucleic acid (DNA) was estimated by indole method (Ceriotti,
1952).
3. Tvrosine was estimated colorimetrically by the method of Lowry et al.
(1951).
4. Estimation of acid ribonuclease was done by treating the homogenate with
RNA solution (3 mg. 'ml.) in acetate buffer at pH 5-2. The reaction was stopped
by adding 10% perchloric acid in alcohol at -10° C. and excess RNA was pre-
cipitated. The activity was expressed as pig. of nucleotides liberated by the
action of RNAase per lug. of tyrosine.
Activities of acid and alkaline phosphatases were measured using sodium
/3-glycerophosphate as substrate at pH 5-2 and 9-2 respectively. Phosphorus
was estimated by Weil-Malherbe and Green's method (1951). Activities ex-
pressed as ,ag. of phosphorus per ,g. of tyrosine.
Adenosine triphosphatase (ATPase) activity was measured by the method of
Krishnan (1955). In this case also ,ug. of phosphorus liberated per /tg. of tyrosine
denoted the enzyme activity.
OBSERVATIONS
Table I shows the amount of nucleic acids in mammary carcinomas in virgins
and breeders of three different strains, and in fibrosarcomas of two different
strains. It may be seen that the levels of both the nucleic acids, as well as ratios
ofRNA'DNA, are comparable in all the tumour types. Acid ribonuclease activity
of these different tumours does not vary significantly.
It is obvious from Table II that all the mammary tumours, either in breeders
or in virgins of different strains, have significantly high alkaline phosphatase
activity and low acid phosphatase activity. It may also be noted that the ratio
of alkaline phosphatase to acid phosphatase activity in breeders is significantly
higher than in the virgins.
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TABLE I.--Contents of ribo- and deoxyribonucleic acids and ribonUclease
activity ofprimary mammary carcinomas and sarcomas in different
strains of mice
Mammary carcinomas
- A
I.C.R.C.
Breeders Virgins
0-354 0*262
+0 04 ±0 07
C3H (Jax)
Breeders Virgins
0-220 0.19
±0O044 ±0-02
Strong A
Breeders
0-188
+0-01
Sarcomas
C3H (Jax) Swiss
0 200 0 296
. ±0-018 ±0-04
DNA. . 0475 0*472 0493 0*43
±0 05 ±014 ±0 11 ±0 04
0 319
±0-01
0 305 0497
±0 03 +0 14
RNA/DNA 0 745 0.555 0 446 0 441 0.590 . 0 66
RNAas . 0 221 0 329 0.183 0 17
±0 04 +0 09 +0-02 +0-05
0.460 0 295
- . ±0± 125 ±0 04
Content of nucleic acids expressed in jig. of nucleic acids per pg. of tyrosine.
RNAase activity expressed as pg. of nucleotides liberated per jug. of tyrosine.
TABLE II.-Activities of acid, alkaline phosphatase and adenosine triphosphatase
ofprimary mammary carcinomas and sarcomas in different strains of mice
Mammary carcinomas
I- A
I.C.R.C. C3H (Jax)
-5 14- , f~~ -A.
I Strong A
Breeders Virgins Breeders Virgins Breeders
Acid
phosphatase
Alkaline
phosphatase
Alkaline
phosphatase/
acid phosphatasE
ATPase
0 25
±0.03
1 61
±0 32
Fibrosarcoma
_ \
C3H (Jax) Swiss
0-234 0-291 0-476 0-39 1*2 1-02
+0-05 ±0-033 ±0-09 ±0-025 ±0- 16 ±0-038
0-876 1-647 1-545 2-21 0-24
±0- 14 ±0-311 ±0-25 ±0-013 ±0-08
0-183
±0-08
6.4 3-8 5-5 3-2 5-7 0-19 0-18
0-062 0-138 0.09 0.14 0.102 0-34 0.225
±0-011 ±0-05 ±0-015 ±0-025 ±0-055 ±0-07 ±0-04
Activities of all the phosphatases expressed in terms of pg. of phosphorus liberated per pg. of
tyrosine.
Fibrosarcomas in both the strains have higher acid phosphatase and lower
alkaline phosphatase activity than the mammary carcinomas. Thus the ratio
of alkaline to acid phosphatase activity drops down as low as 0-17-0-18. Adeno-
sine triphosphatase activity of fibrosarcomas in both the strains is significantly
higher than that of the mammary carcinomas.
Table III shows the levels of ribo- and desoxyribonucleic acids of carcinomas
of different tissue origins. Once again it is proved that nucleic acid levels of
tumours do not vary with tissue origin. The same is the case of ribonuclease
activity.
Table IV shows the activities of acid and alkaline phosphatases and adenosine
triphosphatase activity of carcinomas of different tissue origin. It may be
observed that liver tumours in Strong A and ICRC strains have high alkaline
RNA.
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TABLE III.-Contents ofribo- and deoxyribonucleic acids and ribonuclease
activity offirst generation carcinomas ofdifferent tissue origin in
different strains of mice
Liver Liver Cervix Lung Ascites
(Strong A) (I.C.R.C.) (Strong A) (Swiss) (Strong A)
RNA 0*156 . 0175 . 0*200 0*16 . 0X180
±0.008 ±0-02 ±0 01 . +0*01 . ±0.03
DNA . 0 300 . 0-390 . 0 600 . 0 39 . 0-523
±0-02 . ±0.04 . +0104 0.03 . +0.08
RNA/DNA . . 0 531 . 0-448 . 0.33 . 041 . 0.34
RNAase . . 009 . 0.108 . 0.158 . - . 0.100
+0-02 . +0.04 ±0106 . . ±0.027
Contents of nucleic acids expressed in pg. of nucleic acids per ug. of tyrosine.
RNAase activity expressed as ug. ofnucleotides liberated per jug. oftyrosine.
TABLE IV.-Activities of acid, alkaline phosphatase and adenosine triphosphatase
offirst generation carcinomas ofdifferent tissue origin in different strains of
mice
Liver Liver Cervix Lung Ascites
(A) (I.C.R.C.) (A) (Swiss) (A)
Acidphosphatase . 0 384 . 0-460 . 0283 . 0 168 . 0 320
+0-02 . ±0-045 . ±01012 ±0508 . +0.05
Alkalinephosphatase . . 0 86 1 82 . 0-082 . 0207 . 0-248
±0-016 ±0-28 ±01017 ±008 . ±006
Alkaline phosphatase/ . 2*2 . 40 . 0 29 . 12 . 0 76
acid phosphatase
ATPase . . . 0*120 . 0.07 . 0-156 . 0125 . 0*092
±0-05 ±0017 ±01014 . ±01009 . ±0102
Activities of all the phosphatases expressed in terms ofpug. of phosphorus per pg. of tyrosine.
phosphatase activity and a high ratio of alkaline to acid phosphatase activity.
The cervical tumour has higher acid phosphatase and lower alkaline phosphatase
activity.
Lung and ascites tumour do not show significant differences in acid and alkaline
phosphatase activity. Adenosine triphosphatase activity of these different
carcinomas does not vary significantly.
DISCUSSION
In the previous experiments we had observed that carcinoma (56th generation)
had a lower RNA/DNA ratio and lower incorporation of labelled adenine into
nucleic acids than the sarcoma (46th generation). But from the experiments
reported above it is quite clear that all the tumour types studied display uni-
formity in nucleic acid levels as well as in RNA/DNA ratio. It seems that the
earlier differences noted in two tumours were not due to their histological differ-
ences but due either to the extent of progression of these tumours or to their
growth rate.
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Differences in the activities of acid and alkaline phosphatases of mammary
adenocarcinoma and fibrosarcomas are quite striking. Mammary adenocarcino-
mas possess very high alkaline phosphatase activity and a high ratio of alkaline
to acid phosphatase activity. The normal mammary gland from which these
tumours are derived also possesses remarkably high alkaline phosphatase activity
(Holmes, 1956); the role of this enzyme in mammary gland is not yet elucidated.
Folly (1949) has postulated that it may play an important role in lactose bio-
synthesis. It thus appears that even though the tissue has turned malignant
it has still retained high enzyme activity. A similar instance where the con-
stitutive enzymes are still maintained after malignant transformation is the slow
growing Morris hepatoma (Weber, Banergee and Morris, 1961). This tumour
possesses most of the glycolytic and gluconeogenic enzymes of the normal liver.
Only fast growing hepatomas have shown deletion of constitutive enzymes
(Weber, 1963). It is also interesting to note that mammary carcinomas of the
breeders ofall the three strains show a higher ratio ofalkaline to acid phosphatase
activity than for the corresponding virgin tumours. It was reported previously
that alkaline phosphatase activity of mammary gland increases during pregnancy
and lactation and then declines with involution (Folley and Greenbaum, 1947).
It thus seems to be under the influence of mammotrophic and gonadotrophic
hormones. It will therefore be interesting to study the behaviour of alkaline
phosphatase in mammary gland and mammary tumour under various hormonal
conditions.
The high acid phosphatase activity of fibrosarcomas in both the strains may
also be noted. Characteristically both the tumours have a very low ratio of
alkaline to acid phosphatase activity. Sarcomas also possess higher adenosine
triphosphatase activity than mammary adenocarcinomas. It is known that
muscle, the normal precursor of the tumour has very active ATPase. Higher
adenosine triphosphatase activity in fibrosarcomas could also be due to their
faster rate of growth and hence higher metabolic rate of the tumours. In the
case of carcinomas of different tissues no definite correlation can be established
with reference to phosphatases.
These observations point out the fact that carcinomas as a class cannot be
tagged with biochemical characteristics. Neither nucleic acids nor nucleic acid
ratio has shown any characteristic differences between carcinomas of different
tissues and sarcomas. Significant differences are observed in the case of phos-
phatases. High alkaline phosphatase activity of mammary carcinomas seems
to be the property of normal mammary tissue as well. It thus appears that
useful information for biochemical characterisation of different tumours can be
collected only when specific markers of the tissue of origin are explored. Exten-
sive data on hepatomas has been collected in recent years. Weber (1962), Morris
(1963) and Potter et al. (1960) have been able to correlate the enzymatic make-up
of the hepatoma with its growth rate. Similar search for specific properties of
tumours with reference to the parent tissue will help a great deal to have a clearer
vision of the biochemical nature of the tumours.
SUMMARY
Mammary carcinomas in different strains of mice, carcinomas of different
tissue origins and sarcomas in two strains were studied for (i) nucleic acid levels,
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(ii) acid ribonuclease activity, (iii) acid and alkaline phosphatases, (iv) adenosine
triphosphatase activity. It was observed that nucleic acid content and acid
ribonuclease activity ofall the tumours studied did not show significant differences.
Mammary carcinomas had significantly higher alkaline phosphatase and lower
acid phosphatase activity than fibrosarcomas. Other carcinomas of different
tissue origin did not show any specific correlationship with phosphatase levels.
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